Methylglyoxal-derived AGEs induce tau hyperphosphorylation and impair synapses and memory through RAGE-mediated GSK-3 activation, and targeted inhibition of the RAGE/GSK-3 pathway is effective in ameliorating AD-like histopathological changes and memory deterioration (141). This evidence concerns the gene MAPT and Alzheimer disease.